Dr. Gerard Morton, MD, FRCPC
Claim this profileSunnybrook Health Sciences Centre, Odette Cancer Centre
Studies Prostatic Neoplasm
Studies Prostate Cancer
6 reported clinical trials
8 drugs studied
Area of expertise
1Prostatic Neoplasm
Stage III
Stage I
Stage II
2Prostate Cancer
Stage III
Stage I
Stage II
Affiliated Hospitals
Clinical Trials Gerard Morton, MD, FRCPC is currently running
Rectal Hydrogel Spacer
for Prostate Cancer
There are several single institutional series that have reported their experience with salvage radiotherapy options that include EBRT, LDR and HDR brachytherapy. Gastrointestinal (GI) toxicity with salvage radiotherapy range between14-58%, respectively for patients undergoing re-irradiation. There is a concern for an increased risk of fistula development in these patients who receive second course of radiation. Hypofractionation using SABR has been utilized in the re-irradiation setting for prostate cancer with good tumor control and toxicity outcomes. In order to decrease the rectal toxicity, dose to the rectum should be kept as low as possible. Several techniques can be used to achieve this: tighter dosimetric dose painting, better patient or organ immobilization or use of a biodegradable gel. The Investigators ropose a phase I study to assess placement of a hydrogel spacer between the prostate and rectum, in an effort to decrease toxicity and improve patient's bowel quality of life.
Recruiting1 award N/A
SBRT vs. Conventional Radiation
for Prostate Cancer
This trial compares two types of radiation treatments for men with prostate cancer. It aims to see if a shorter, intense treatment is as effective as a longer one. Both treatments use high doses of radiation to kill cancer cells. The modern technique delivers high doses in fewer sessions, showing promise in terms of safety, effectiveness, and cost.
Recruiting1 award N/A5 criteria
More about Gerard Morton, MD, FRCPC
Clinical Trial Related7 years of experience running clinical trials · Led 6 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Gerard Morton, MD, FRCPC has experience with
- Conventionally Fractionated Radiation
- Sterotactic Body Radiotherapy
- Focal Salvage HDR Brachytherapy
- SABR
- HDR Brachytherapy
- SpaceOAR
Breakdown of trials Gerard Morton, MD, FRCPC has run
Prostatic Neoplasm
Prostate Cancer
Relapse
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
What does Gerard Morton, MD, FRCPC specialize in?
Is Gerard Morton, MD, FRCPC currently recruiting for clinical trials?
Are there any treatments that Gerard Morton, MD, FRCPC has studied deeply?
What is the best way to schedule an appointment with Gerard Morton, MD, FRCPC?
What is the office address of Gerard Morton, MD, FRCPC?
Is there any support for travel costs?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.